U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Liraglutide Injection
Status: Currently in Shortage
»Date first posted: 07/18/2023
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Hikma Pharmaceuticals USA, Inc. (New 04/02/2025)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) Available Product will be made available as it is released.
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) Available Product will be made available as it is released.

Novo Nordisk, Inc. (Reverified 03/24/2025)

Company Contact Information:
833-493-4689

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) Limited Availability Estimated shortage duration TBD Demand increase for the drug
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) Limited Availability Estimated shortage duration TBD Delay in shipping of the drug
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) Limited Availability Estimated shortage duration TBD Delay in shipping of the drug
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) Available Distributed by Teva
Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) Available Distributed by Teva
Back to Top